CD44 and breast carcinoma: TNBCs, the basal subtype of breast cancer, which is highly metastatic due to the presence of CD24−/CD44+‐breast CSCs, often express epidermal growth factor receptor (EGFR) in high levels, which serve as a biomarker.6